AMRUTANJANNSEAmrutanjan Health Care Limited· PharmaceuticalsMinimalNeutral
Announced Tue, 24 Mar · 15:02 IST

Amrutanjan Health Care Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015

AMRUTANJAN · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
-0.8%1-day move
₹523.70
prior close
₹530.70
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.2-0.0+0.5-0.8-3.2-6.1-4.8-3.0-2.2+4.1+10.8+8.0+4.0
Up moveDown movePending
AI summary

Amrutanjan Health Care has informed the stock exchanges that its trading window for dealing in company securities will be closed for designated persons starting April 1, 2026. The closure is in line with SEBI's Prohibition of Insider Trading Regulations, 2015 and the company's internal code of conduct. The window will remain shut until 48 hours after the company declares its audited financial results for the quarter and full year ending March 31, 2026. Designated persons, including insiders, have been instructed not to trade in the company's shares during this period. This is a standard compliance filing made ahead of the annual earnings announcement.

Likely market impact

This is a routine regulatory disclosure with no direct impact on the stock price. However, it signals that the company's Q4 and FY26 audited results announcement is likely coming up soon, which investors should watch for.